Scientists at Inserm and Institut Pasteur has developed a prognostic test that can predict the efficacy of hepatitis C treatments has been developed. The commercialisation of the test is expected in 2011.  This test can predict the treatment efficacy of pegylated-interferon and ribavirin



Be a part of Elets Collaborative Initiatives. Join Us for Upcoming Events and explore business opportunities. Like us on Facebook , connect with us on LinkedIn and follow us on Twitter , Instagram.

Related Research


whatsapp--v1